Literature DB >> 24723288

Patient attrition between the emergency department and clinic among individuals presenting for HIV nonoccupational postexposure prophylaxis.

Isaac I Bogoch1, Eileen P Scully, Kimon C Zachary, Sigal Yawetz, Kenneth H Mayer, Chaim M Bell, Jason R Andrews.   

Abstract

BACKGROUND: Nonoccupational postexposure prophylaxis (nPEP) is recommended after a sexual or parenteral exposure to human immunodeficiency virus (HIV). Patients frequently seek care in an emergency department (ED) after an exposure and are usually referred to an HIV clinic for further management. There have been few data on determinants of attrition after presentation to EDs for nPEP.
METHODS: From July 2010 to June 2011, we prospectively recorded all referrals to nPEP programs from 2 large EDs at 2 academic medical centers in Boston, Massachusetts. Data were recorded on patient demographics, nature of potential HIV exposures, referrals to and attendance at HIV clinics, and reported completion of 28 days of antiretroviral therapy (ART). Multivariable logistic regression was used to evaluate risk factors for (1) patient attrition between the ED and HIV clinic follow-up and (2) documented completion of ART.
RESULTS: Of 180 individuals who were referred to clinic follow-up for nPEP care from the ED, 98 (54.4%) attended a first nPEP clinic visit and 43 (23.9%) had documented completion of a 28-day course of ART. Multivariable analysis revealed older age (adjusted odds ratio [aOR], 0.96; 95% confidence interval [CI], .93-.99) and self-payment (aOR, 0.32; 95% CI, .11-.97) were significant predictors for failing to attend an initial HIV clinic appointment. Women were less likely than men to complete a 28-day ART regimen (aOR, 0.34; 95% CI, .15-.79).
CONCLUSIONS: Commonly used nPEP delivery models may not be effective for all patients who present with nonoccupational exposures to HIV. Interventions are needed to improve rates of follow-up and completion of nPEP to reduce the risk of preventable HIV infections.

Entities:  

Keywords:  HIV; care linkage; postexposure prophylaxis; prevention; retention

Mesh:

Year:  2014        PMID: 24723288     DOI: 10.1093/cid/ciu118

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.

Authors:  Sachin Jain; Douglas S Krakower; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2015-06-01       Impact factor: 9.079

2.  Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens.

Authors:  Kenneth H Mayer; Daniel Jones; Catherine Oldenburg; Sachin Jain; Marcy Gelman; Shayne Zaslow; Chris Grasso; Matthew J Mimiaga
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-15       Impact factor: 3.731

3.  "It's Like Plan B but for HIV!" Design and Evaluation of a Media Campaign to Drive Demand for PEP.

Authors:  Jeremy Fagan; Victoria Frye; Rose Calixte; Sachin Jain; Lovely Molla; Adeola Lawal; Marcus P Mosley; Emily Greene; Kenneth H Mayer; Barry S Zingman
Journal:  AIDS Behav       Date:  2020-12

4.  Uptake and repeat use of postexposure prophylaxis in a community-based clinic in Los Angeles, California.

Authors:  Matthew R Beymer; Robert K Bolan; Risa P Flynn; Dustin R Kerrone; David L Pieribone; Sonali P Kulkarni; Jackelyn C Stitt; Everardo Mejia; Raphael J Landovitz
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-29       Impact factor: 2.205

5.  A mixed methods study of non-occupational post-exposure prophylaxis at an STI clinic in Singapore: Five-year retrospective analysis and providers' perspectives.

Authors:  Alvin Kuo Jing Teo; Bee Choo Tai; Martin Tze-Wei Chio; Hanh Hao La
Journal:  PLoS One       Date:  2018-08-20       Impact factor: 3.240

6.  Prescription of Non-Occupational Post-Exposure HIV Prophylaxis by Emergency Physicians: An Analysis on Accuracy of Prescription and Compliance.

Authors:  Stefano Malinverni; Agnès Libois; Anne-Françoise Gennotte; Cécile La Morté; Pierre Mols
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

7.  Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort.

Authors:  Réjean Thomas; Chrissi Galanakis; Sylvie Vézina; Danièle Longpré; Michel Boissonnault; Emmanuelle Huchet; Louise Charest; Daniel Murphy; Benoît Trottier; Nimâ Machouf
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.